Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study
2023 · Journal of Clinical Medicine · 6 citations
https://doi.org/10.3390/jcm12154912
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
46
Citations
5
h-index
1
i10-index
Federica Carlea is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Inflammatory Biomarkers in Disease Prognosis & Myasthenia Gravis and Thymoma. The author has an h-index of 5, co-authored 10 publications.
https://doi.org/10.3390/jcm12154912
https://doi.org/10.1007/s10195-012-0208-9
https://doi.org/10.1245/s10434-026-19281-1
Click to start Chat